EarningsQ1 2023 Earnings Report

Relmada Therapeutics (4E2) Q1 2023 Earnings Report

0 Followers

DE:4E2 Q1 2023 EPS Results

Actual EPS-€0.77

Consensus EPS-€0.79

Beat/MissBeat by +€0.02

One Year Ago EPS-€1.24

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ1 2023

Date05/11/2023

TimeAfter Close

Conference CallThursday, May 11, 2023

DE:4E2 Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:4E2 Q1 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.13 / -	-0.266	―
Aug 06, 2026	2026 (Q2)	-0.18 / -0.10	-0.266	63.33% (+0.17)
May 12, 2026	2026 (Q1)	-0.18 / -0.20	-0.515	62.07% (+0.32)
Mar 19, 2026	2025 (Q4)	-0.13 / -0.24	-0.551	56.45% (+0.31)
Nov 13, 2025	2025 (Q3)	-0.38 / -0.27	-0.639	58.33% (+0.37)
Aug 07, 2025	2025 (Q2)	-0.41 / -0.27	-0.524	49.15% (+0.26)
May 12, 2025	2025 (Q1)	-0.43 / -0.52	-0.639	19.44% (+0.12)
Mar 27, 2025	2024 (Q4)	-0.60 / -0.55	-0.746	26.19% (+0.20)
Nov 07, 2024	2024 (Q3)	-0.60 / -0.64	-0.648	1.37% (<+0.01)
Aug 07, 2024	2024 (Q2)	-0.74 / -0.52	-0.746	29.76% (+0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed